04:26 AM EDT, 05/07/2024 (MT Newswires) -- RxSight ( RXST ) reported a Q1 adjusted loss late Monday of $0.12 per diluted share, narrowing from a loss of $0.31 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.19.

Revenue for the quarter ended March 31 was $29.5 million, up from $17.5 million a year earlier.

Analysts surveyed by Capital IQ expected $27.6 million.

For 2024, the company raised its revenue guidance to $132 million to $137 million from prior guidance of $128 million to $135 million. Analysts surveyed by Capital IQ expect $134.9 million.